The transformant cell lines generated by chromosomemediated gene transfer share the following general properties. First, no donor chromosomes or chromosome fragments are detectable cytologically. Second, isozyme analyses of transformant cell lines unambiguously demonstrate expression of the complementing gene derived from the donor cells (1, (3) (4) (5) (6) 8) , and, in some cases (9, 10), coexpression of tightly linked loci. Unlinked markers characteristic of the donor cells are not present in the transformant clones (3). Third, expression of the transferred marker may be stable or unstable. Unstable lines lose the transferred genetic element ("transgenome") at different rates (usually 1-10% per cell generation) (1, 3, 10) , and can give rise to stably transformed lines upon prolonged cultivation (6, 9). Such stable lines seem to express the transferred marker as an integral genetic element of the host cell.
Chromosome-mediated gene transfer is a technique that allows small pieces of genetic material to be transferred from one mammalian cell to another (1) (2) (3) (4) (5) (6) . This process, which was convincingly demonstrated by McBride and Ozer in 1973 (1) , utilizes isolated metaphase chromosomes as vectors for genetic exchange. According to current views (7), chromosomes enter the recipient cells by phagocytosis and are subsequently de- graded by lysosomal enzymes. By using appropriate selective conditions, transformant clones that express a particular donor-derived phenotype can be isolated at low frequency. Both intra-and interspecific gene transfer experiments have been reported using mouse, Chinese hamster, and human somatic cells, and a variety of selectable markers have been transferred (1) (2) (3) (4) (5) (6) (7) (8) .
The transformant cell lines generated by chromosomemediated gene transfer share the following general properties. First, no donor chromosomes or chromosome fragments are detectable cytologically. Second, isozyme analyses of transformant cell lines unambiguously demonstrate expression of the complementing gene derived from the donor cells (1, (3) (4) (5) (6) 8) , and, in some cases (9, 10) , coexpression of tightly linked loci. Unlinked markers characteristic of the donor cells are not present in the transformant clones (3) . Third, expression of the transferred marker may be stable or unstable. Unstable lines lose the transferred genetic element ("transgenome") at different rates (usually 1-10% per cell generation) (1, 3, 10) , and can give rise to stably transformed lines upon prolonged cultivation (6, 9) . Such stable lines seem to express the transferred marker as an integral genetic element of the host cell.
Little is known concerning the state, physical nature, or location of the transgenome in either stable or unstable gene transfer clones. (14) and selecting for the expression of (human) HPRT using the hypoxanthine/aminopterin/thymidine (HAT) selective system (15) . The generation of such microcell hybrids has been described elsewhere (12) . Inde' pendent microcell hybrid clones were picked by the ring technique and expanded. Electrophoretic analyses of hybrid cell extracts were performed using published procedures (16, 17 All hybrid clones were subject to back-selection in medium containing 6-thioguanine (10 sg/ml) and 8-azaguanine (30 jig/ml) and the resulting HPRT-populations were characterized as described above without subcloning.
RESULTS
The microcell hybrids generated by fusion of CT1 1CI microcells with intact E36 recipients had either a single (IS hybrids) or a double (2S hybrids) input of Chinese hamster chromosomes characteristic of E36 (IS modal chromosome number = 21) and also contained from one to four mouse chromosomes derived from CT1 1CI. In addition, electrophoretic analyses of extracts prepared from each of the microcell hybrids demonstrated that the cells expressed the human and only the human form of HPRT. We have used the descriptive term "tribrid" to emphasize the trispecific nature of these cells. The characterization of individual tribrid clones is considered in detail below. Fig. 1 shows the distribution of introduced mouse chromosomes in several tribrid lines and their 8-azaguanine-, 6-thioguanine-resistant back-selectants. ECm-2 was a typical IS tribrid that contained 21 Chinese hamster chromosomes. In addition, the majority (>80%) of cells in this population contained a single mouse chromocenter. Detailed karyotyping of Gietusa/viokase-banded preparations (25 metaphase spreads examined) showed that a particular small telocentric murine chromosomrie derived from CT11C, was present in >90% of the cells (Fig. 2) . Electrophoretic analyses were performed for twenty isozymes representing at least eight murine linkage groups (Table  1) . ECm-2 clearly expressed the human and only the human form of HPRT (Fig. 3) . Therefore, the transgenome-encoded selectable marker had been successfully transferred from a stable gene-transfer line to a hamster recipient using a chromosome transfer methodology. Despite the presence at high frequency of a particular mouse chromosome in ECm-2, no murine isozymes were detected in the clone. This was not unexpected because the presence of about half of the mouse linkage groups would not have been revealed by our isozyme analyses. Significantly, murine a-galactosidase, an X-linked marker, was not present in ECm-2.
ECm-2 was subjected to back selection in medium containing azaguanine and thioguanine and three independently derived subpopulations were produced (designated ECm2AT1, -2, and -3). These subpopulations had lost expression of human HPRT. Concordant with the loss of human HPRT activity, the telocentric murine chromosome characteristic of ECm-2 was also lost. Fig. 1 These data show concordant segregation of human HPRT activity and a particular murine chromosome and provide strong genetic evidence for the hypothesis that the transgenome had become stably associated with a host chromosome in CT1 1CI. Because neither murine X chromosomes nor X-linked markers were present in ECm-2, this association seems not to have occurred at the homologous locus of the murine genome. These conclusions were strengthened and amplified by characterizing other independent tribrid clones. 
Dipeptidase-1
na CM C C C C C Extracts of the hybrid cell lines were analyzed according to published procedures (16, 17) . The data for the three HPRT-back-selectant populations produced from each primary tribrid are presented in a single column. The murine chromosome assignment refers to the normal diploid karyotype. C, Chinese hamster; M, mouse; H, human; -, isozyme activity not detected; na, not assigned. present in >90% (15/16 karyotypes) of the cells (Fig. 1) . This large telocentric chromosome was one of several present in CT 1CI (and in its A9 parent) that did not exhibit a brightly fluorescent centromere when stained with Hoechst 33258 (19) . The banding characteristics of this chromosome and the isozyme data (see below) suggested that it was a rearranged murine chromosome 14. ECm-1 expressed the human form of HPRT (Fig. 3) . Murine isozymes were also present in this tribrid clone (Table 1) . These included purine-nucleoside phosphorylase and esterase-10, syntenic markers assigned to mouse chromosome 14, as well as tripeptidase-1, an isozyme that has not yet been mapped in the murine genome. No other mouse isozymes were detected in ECm-1, including the X-linked marker a-galactosidase.
The azaguanine and thioguanine-resistant back-selectants of ECm-1 (ECmIATi, -2, and -3) no longer expressed human HPRT. Moreover, none of the three back-selectants expressed the murine forms of purine-nucleoside phosphorylase, esterase-10, and tripeptidase-I (Table 1) . Karyotypes showed that the large telocentric chromosome present in the ECm-1 primary tribrid had been uniformly segregated from the backselectants. The data for ECm1AT2 are illustrated in Fig. 1 . Fourteen of fifteen karyotypes consisted only of hamster chromosomes. In one karyotype, one murine chromosome was present but was distinct from the mouse chromosome-14-analogue present in ECm-1. As was observed for the ECm-2 back-selectants, no HAT-resistant colonies could be recovered from ECmiATi, -2, or -3, using inocula as large as 107 cells.
These data have shown that in both ECm-1 and ECm-2 the human transgenome was associated with a murine chromosome with which it segregated concordantly. However, the particular mouse chromosome involved was clearly distinct in these two tribrid clones. We conclude that the stable association of the (±) origin -_ 2 3 4 5 6 7 8 9 10 FIG. 3. Autoradiograph of HPRT activity in extracts after electrophoretic separation (16, 17 ECm-4 was a 2S tribrid clone which was karyotypically heterogeneous. Individual cells of this clonal population contained two to five introduced mouse chromosomes (Fig. 1 ). Among these were several different telocentric chromosomes, none of which was present in the population at high frequency. All cells karyotyped also contained at least one metacentric murine chromosome. Upon selection for the HPRT-phenotype, a single mouse chromosome disappeared from the population (Fig. 1) . The particular chromosome lost seemed to be one of the murine metacentrics.
The metacentric mouse chromosomes present in ECm-4 were very similar in size and in banding pattern. However, in very well-banded preparations it became clear that there were two distinct metacentric chromosomes derived from CT1 1Ci present in ECm-4. One of these chromosomes was found in about 50% of the karyotypes of both ECm-4 and its ECm4AT1 back-selectant. This was a murine isochromosome 15 (Fig. 4) . The other metacentric was present at high frequency in ECm-4 but absent from its back-selectants. One arm of this chromosome had a banding pattern identical to that of a normal mouse chromosome 15, while the other arm seemed to be derived from murine chromosome 14. These data indicated that the human transgenome had become stably associated with a particular metacentric murine chromosome (designated 14/15) composed of elements of mouse chromosomes 14 and 15. This interpretation was strengthened by isozyme analyses which showed concordant segregation of human HPRT activity with the phenotypic markers of murine chromosome 14, purine-nucleoside phosphorylase and esterase-10 (Table 1) . In order to verify this conclusion, we performed subeloning experiments.
Ten independent, HAT-resistant subclones were prepared from ECm-4. More than 85% of the cells of one subclone (ECm-4e) contained a single murine chromosome (Fig. 1) . The particular murine chromosome present in the cells was the 14/15 metacentric of ECm-4 and was found in all 28 cells karyotyped (Fig. 4) . Like ECm-4, ECm-4e expressed murine esterase-10 and purine-nucleoside phosphorylase in addition to human HPRT (Table 1) .
Concordant segregation of human HPRT activity and the two isozymes of mouse chromosome 14 was observed in three azaguanine-and thioguanine-resistant back-selectants (ECm4eAT1, -3, and -5) prepared from ECm-4e ( (1977) chromosomes in unstable lines. Using microcells derived from various unstable gene-transfer clones in chromosome transfer studies similar to those reported here, we have been unable to introduce the transgenome-encoded selectable marker into HPRT-hamster cells despite repeated attempts (six hybridization experiments).
Irrespective of the exact mode of interaction of the transgenome with host chromosomes, our results indicate that this association is sufficiently stable to allow the construction of new genetic tools. Specifically, it is now possible to introduce a transgenome-encoded selectable marker into a variety of chromosomes of any mammalian species. Using a chromosome transfer approach, these marked chromosomes can be transferred to a third species which would serve as a carrier. Thus, a series of hamster cell lines could be constructed, each containing a single and unique murine chromosome carrying the human transgenome and maintained in the population at high frequency by selection. Such novel gene assignment panels would be precisely defined and would eliminate the karyotypic instability that has been encountered in more conventional gene assignment panels. By appropriate experimental design, such panels could be constructed for any mammalian species of choice.
